Core Laboratories Inc. /DE/·4

May 4, 4:37 PM ET

Tattoli Mark Damian 4

Research Summary

AI-generated summary

Updated

Core Laboratories (CLB) SVP Mark Tattoli Exercises Derivatives, Sells 97 Shares

What Happened

  • Mark Damian Tattoli, Senior Vice President, General Counsel & Secretary of Core Laboratories (CLB), recorded derivative exercise/conversions on May 1, 2026. The filing shows an acquisition of 250 shares via exercise/conversion (code M) and a simultaneous disposition of 250 derivative shares (code M, $0 price). Separately, 97 shares were disposed to cover tax withholding (code F) at $14.07 per share for a total of $1,365.

Key Details

  • Transaction date(s): May 1, 2026. Form filed: May 4, 2026 (timely filing).
  • Derivative activity: 250 shares acquired (exercise/conversion, code M, $0 price) and 250 derivative shares disposed (code M, $0 price).
  • Tax withholding: 97 shares surrendered/disposed at $14.07 each = $1,365 (code F).
  • Shares owned after the reported transactions: not specified in the provided filing excerpt.
  • Footnotes: F1 — Restricted shares vest annually over six years if service continues; F2 — multiple restricted share grants are included in the total.
  • No indication this is a 10% owner transaction or a 10b5-1 plan in the excerpt.

Context

  • The M codes indicate exercise or conversion of derivative awards (e.g., options or vested restricted share units). The filing pattern — acquisition plus an immediate disposition and a small share surrender for taxes — is commonly a routine net settlement or tax-withholding action tied to vesting or exercise, not necessarily a directional bet on the stock.
  • Purchases by insiders tend to be considered more informative than routine exercises or tax-withholdings; this filing primarily documents internal compensation mechanics rather than an open-market buy or sell.